Content Block Tag: NRG-HN006: SLN Biopsy for ES Oral Cavity Cancer

‘Text/HTML’ of page ‘NRG-HN006: SLN Biopsy for ES Oral Cavity Cancer’

Am I eligible for this study? People who have a proven diagnosis of squamous cell carcinoma of the oral cavity and who are candidates for surgical intervention with SNL biopsy, complete neck dissection, or END, may be eligible for the study. Your healthcare team is the best source for information about your treatment options, including […]

‘Text/HTML’ of page ‘NRG-HN006: SLN Biopsy for ES Oral Cavity Cancer’

About This Study NRG-HN006 is a clinical study that seeks to determine if patient-reported neck and shoulder function and related quality of life is better six months after surgery using Sentinel Lymph Node (SLN) biopsy compared to Elective Neck Dissection (END) for treatment of early-stage oral cavity squamous cell carcinoma (OCSCC) (clinical stage T1-2N0). […]

‘Text/HTML’ of page ‘NRG-HN006: SLN Biopsy for ES Oral Cavity Cancer’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-HN006: SLN Biopsy for ES Oral Cavity Cancer’

The NRG-HN006 Study FAQ